Norplant effective, but will not be relaunched
This article was originally published in Clinica
Executive Summary
Wyeth Pharmaceuticals has decided not to return the Norplant implantable contraceptive device to the market, some two years after being withdrawn because of concerns over the effectiveness of certain lots. At the same time, the company announced that the product can now be safely used without back-up contraceptive methods.